We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.

First reported Oct 20, 2026, 18:10 UTC

Source reports

We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients… — @OpenAI (X), Oct 20, 2026, 18:10 UTC
OpenAI acquires Orchestra Bio to streamline drug development operations - 𝕏/@OpenAI 🔗 Discord · Leviathan · Source 🗺️ OpenAI · Acquisition 🕵️ @Danicjade via 𝕏 — Rickler Feed, Oct 20, 2026, 19:38 UTC
OpenAI acquires Orchestra Bio to streamline drug development operations - 𝕏/@OpenAI 🔗 Discord · Leviathan · Source 🗺️ OpenAI · Acquisition 🕵️ @Danicjade via 𝕏 — Закрепи.sender, Oct 20, 2026, 19:38 UTC

Excerpts are quoted from the linked sources, which own their text.